Astec LifeSciences Limited (NSE:ASTEC)
India
· Delayed Price · Currency is INR | Market Cap | 16.19B |
| Revenue (ttm) | 4.53B |
| Net Income (ttm) | -809.18M |
| Shares Out | 22.28M |
| EPS (ttm) | -37.79 |
| PE Ratio | n/a |
| Forward PE | 46.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 74,297 |
| Average Volume | 418,593 |
| Open | 733.00 |
| Previous Close | 726.75 |
| Day's Range | 692.45 - 735.50 |
| 52-Week Range | 513.40 - 998.40 |
| Beta | -0.14 |
| RSI | 60.45 |
| Earnings Date | Apr 27, 2026 |
About Astec LifeSciences
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insec... [Read more]
Financial Performance
In fiscal year 2026, Astec LifeSciences's revenue was 4.53 billion, an increase of 18.86% compared to the previous year's 3.81 billion. Losses were -809.18 million, -39.95% less than in 2025.
Financial StatementsNews
Astec LifeSciences approves audited financial results for FY26
Astec LifeSciences has announced the approval of its audited financial results for the quarter and financial year ended 31st March 2026. The decision was made during a Board meeting held…
Astec LifeSciences reports ₹161.3 crore income in Q4 FY26, a 34% increase
Astec LifeSciences Limited has announced its consolidated financial results for the fourth quarter and year ended 31st March 2026, showcasing significant growth in revenue and a reduction in losses. I...
Astec LifeSciences reports 34% revenue growth in Q4 FY26 with ₹161.3 crore income
Astec LifeSciences Limited has announced its financial results for the fourth quarter and the financial year ending 31st March 2026, showcasing a robust performance. The company reported a consolidate...
Nadir Godrej to step down as chairperson of Godrej Industries, Godrej Agrovet and Astec LifeSciences; new leadership announced
Nadir Godrej will step down as chairperson across three listed Godrej Group companies — Godrej Industries, Godrej Agrovet and Astec LifeSciences — as he approaches the age of 75 in…
Astec LifeSciences appoints Vishal Sharma as chairperson following Nadir Godrej's retirement
Astec LifeSciences has announced significant changes in its board of directors, including the retirement of Mr. Nadir Godrej as Chairperson and Director, effective 13th April, 2026. Mr. Godrej's depar...
Astec LifeSciences confirms Rs 4.36 crore interest payment on debentures
Astec LifeSciences has confirmed the timely payment of interest on its non-convertible debentures, amounting to ₹4,36,10,000. The payment was made on the due date of 27th March 2026, as per…
Astec Lifesciences shares rally sharply over 18% today: Details here
Astec Lifesciences shares witnessed a sharp rally on Wednesday, surging over 18% intraday and drawing strong investor attention on Dalal Street. The stock touched a high of ₹620.95 during the…
Astec LifeSciences sells asset to Clean Max Enviro for Rs 26,000
Astec LifeSciences has completed the sale of an asset to Clean Max Enviro Energy Solutions, receiving a consideration of ₹26,000 for the transaction. The agreement for sale was entered into…
Astec Lifesciences shares rally over 7% today; Details here
Astec Lifesciences witnessed a sharp upward move in today’s session, with the stock rising more than 7% amid strong trading...
Astec Lifesciences shares jump over 7% today; Details here
Astec Lifesciences saw a strong upswing in early Friday trade, with the stock rallying more than 7%. The share opened...
Astec LifeSciences shares rise over 4% after Burjis Godrej appointed as Managing Director
Shares of Astec LifeSciences surged 4.58% to Rs 706.15 in Monday’s session after the company appointed Burjis Godrej as Managing Director for a five-year term starting April 1, 2025. Burjis, the elder...